Skip to main content
Senti Biosciences, Inc. logo

Senti Biosciences, Inc. — Investor Relations & Filings

Ticker · SNTI ISIN · US81726A1007 US Professional, scientific and technical activities
Open in API
Filings indexed 318 across all filing types
Latest filing 2021-05-07 Regulatory Filings
Country US United States of America
Listing US SNTI

About Senti Biosciences, Inc.

https://www.sentibio.com/

Senti Biosciences, Inc. is a clinical-stage biotechnology company developing a new generation of cell and gene therapies. The company's core technology is its synthetic biology platform, which designs and optimizes proprietary "Gene Circuits." These circuits, created from novel combinations of DNA sequences, are engineered to reprogram cells with biological logic, enabling them to sense inputs, compute decisions, and respond to their cellular environments. This approach aims to create smarter medicines with enhanced therapeutic effectiveness and safety. Senti Bio is applying its Gene Circuit technology to develop a pipeline of product candidates, primarily for the treatment of cancer, designed to precisely target and eliminate malignant cells while sparing healthy tissue.

Recent filings

Filing Released Lang Actions
FORM S-1
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for initial public offerings (IPOs) to register securities. It includes detailed information about the offering, the company, management, risk factors, use of proceeds, and financial statements. This is not an annual or quarterly report, nor is it an earnings release or a proxy statement. It is a regulatory filing specific to the registration of securities for public sale under the Securities Act of 1933. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is a full registration statement, not a brief announcement or certification.
2021-05-07 English
Regulatory Filings 2021
Regulatory Filings
2021-04-30 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC, as indicated by the header and content. It is a preliminary prospectus for an initial public offering (IPO) of securities by Dynamics Special Purpose Corp. The document includes detailed information about the offering, securities, underwriting, risk factors, management, and financial data. Form S-1 is a registration statement used for new securities offerings and is not a financial report like an annual or quarterly report. It is also not an announcement or a brief summary but a comprehensive registration filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and filings that do not fit other specific categories. The document length (15,000 characters) and detailed content confirm it is not a mere announcement or certification but a full regulatory filing.
2021-04-02 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.